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Background: Aflatoxin B, (compound 5) is a potent environmental carcinogen 
produced by certain Aspergihs species. Its first stable biosynthetic precursor is 
the anthraquinone norsolorinic acid (compound 3), which accumulates in the 
Aspergillus mutant strain NOR-l. Biochemical and genetic evidence suggest that 
this metabolite is synthesized in viva by a specialized pair of fatty acid synthases 
(FAS-1 and FAS-2) and a separately transcribed polyketide synthase (PKS-A). 
Results: The N-acetylcysteamine (NAC) thioester of hexanoic acid was shown 
to efficiently support the biosynthesis of norsolorinic acid (compound 3) in the 
NOR-I strain. In contrast, the mutants Dis-1 and Dis-2, which are derived from 
NOR-1 by insertional inactivation of fas-I, produced unexpectedly low amounts 
of norsolorinic acid in the presence of hexanoylNAC. Controls eliminated defects 
in the parent strain or enhancement of degradative B-oxidation activity as an 
explanation for the low level of production. Southern blots and restriction 
mapping of Dis-1 and Dis-2 suggested normal levels of expression of the PKS-A 
and FAS-2 proteins should be observed because the genes encoding these 
proteins are not physically altered by disruption of fas-7. 
Conclusions: The impaired ability of Dis-I and Dis-2, harboring modified FAS-1 
enzymes, to carry out norsolorinic acid synthesis implies the need for FAS-1 (and 
possibly also FAS-2) to physically associate with the PKS before biosynthesis 
can begin. The failure of the unaffected PKS alone to be efficiently primed by 
hexanoylNAC, and the presumed requirement for at least one of the FAS proteins 
to bind and transfer the C, unit to the PKS, is in contrast to behavior widely 
believed to occur for type I PKSs. 
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Introduction 
Among natural products, the polyketides have achieved 
prominence in recent years not only for their important 
biological activities as, for example, antibiotics, immuno- 
suppressants, antiparasitics and toxins, but also for the 
seminal advances that have been made at the genetic 
[l-3] and protein levels [4-91 in understanding the 
primary engines of their synthesis in nature, the 
polyketide synthases (PKSs). These large, macro- 
molecular machines bear strong similarities to fatty acid 
synthases (FASs) but extend their synthetic power 
considerably [lo]. The FASs typically homologate acetate 
by successive decarboxylative Claisen condensations with 
malonate followed by reduction and dehydration steps to 
yield the saturated hydrocarbon chain of a fatty acid (Fig. 
1, R = R’ = H). The PKSs use similar chemistry to achieve 
impressive synthetic versatility. They can also use low 
molecular weight primers other than acetate, and can 
catalyze homologation steps with malonate and with a 
variety of its ol-alkylated derivatives. The reduction and 
dehydration steps carried out by PKSs may take place 
using a ‘processive’ elongation process in a manner similar 
to that of the FAS-catalyzed reactions; however, that series 
of steps may not be completed, yielding successive 
carboxyl-derived carbons at the oxidation state of a 
ketone, alcohol/double bond or methylene in the growing 
polyketide chain (Fig. 1; with both R and S configurations 
possible at the positions marked by a star). 
Aflatoxin B, (compound 5, Fig. 2) is a potent environ- 
mental carcinogen produced by certain Aspergdhs species, 
which are vigorously growing fungi that infect, among 
other things, grains and nuts. The mycotoxin survives 
food processing to become an important contaminant of 
foodstuffs worldwide [11,12]. It has been directly linked 
to carcinomas of the liver and kidney [13,14] as a result of 
interaction of its metabolically activated form with DNA, 
notably the ~53 gene in humans. 
The biosynthesis of aflatoxin is unusually long and 
complex [15-181, but is known to begin with norsolorinic 
acid (compound 3, Fig. 2) - a metabolite that is clearly 
of polyketide origin [ 191. This tetrahydroxyanthraquin- 
one is thought to be derived from the corresponding 
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anthrone 2 based on experiments with lsOZ in which 
C-10 is uniquely labeled [ZO] (Fig. 2). The mechanism of 
formation of compound 2 has been investigated by 
extensive 13C-incorporation studies with C,, C, and C, 
acids and their corresponding N-acetylcysteamine (NAC) 
thioesters [Zl-231, which were prepared as potential 
surrogates of the hypothetical CoA or acyl carrier protein 
(ACP) thioester intermediates. These studies, as well as 
IsO labeling experiments [Zl] and stereochemical corre- 
lations [24], point decisively to either of two mechanistic 
possibilities in the formation of compound 2 [ZS]. The 
first would involve a polyfunctional enzyme that acts as a 
FAS to homologate acetate, generating a six carbon unit, 
before adding, as a PKS, malonate units without any 
reductive steps to generate a hypothetical enzyme-bound 
intermediate 1 [ 131. Alternatively, the hexanoyl starter 
unit could be synthesized by a specialized FAS that 
releases, for example, hexanoylCoA or hexanoylACP. 
Such an enzyme could also channel its product to a 
distinct PKS with which it was complexed to lead on to 
the synthesis of intermediate 1 [Zl]. Although proposed 
intermediates such as 1 have never been detected, the 
central dogma of polyketide biosynthesis holds that 
highly reactive species such as these are generated before 
intramolecular aldol condensation, dehydration, aromati- 
zation and expulsion of the enzyme active-site thiol, 
which would result in the production of the anthrone 2 in 
a powerfully exothermic process. We can only speculate 
on the folding and exact sequence of reactions of the 
polyketide intermediates; for example, the reactions may 
occur in a stepwise manner to form first the A-ring, then 
the B-ring and, finally, the C-ring as each of the last two 
reactions with malonate take place. 
Consistent with the second reaction mechanism involving 
two distinct enzymatic activities, genetic evidence has 
recently implicated two specialized FASs (FAS-1 and 
FAS-2) as being jointly responsible for the formation of 
the C, precursor, which would then serve as the substrate 
for a separately transcribed PKS. Insertional inactivation 
of the putative PKS gene (p&A) gave a mutant unable to 
synthesize aflatoxin or any detectable pathway inter- 
mediate [26,27]. Sequence alignments indicate that this 
PKS contains four recognizable domains: an acylcarrier 
protein, a P-ketoacyl synthase, an acyltransferase and a 
thioesterase. Reduction/dehydration domains character- 
istic of FAS proteins are notably absent. Insertional 
inactivations offas- gave the mutants Dis-1 and Dis-2, 
which are unable to incorporate acetate into the aflatoxin 
pathway [28]. Sequence analysis shows that FAS-1 and 
FAS-2 have a high degree of identity to the yeast FAS p 
and 01 subunits, respectively [29], and together include all 
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An overview of aflatoxin biosynthesis. It is proposed that FAS enzymes synthesize the hexanoyl starter unit (in blue) to which a PKS homologates 
malonyl units (in red) to initiate anthrone formation and aflatoxin biosynthesis. 
the catalytic domains required for fatty acid synthesis. 
Here, we provide biochemical evidence to support the 
roles of the PKS and the FASs in aflatoxin biosynthesis, 
which have been deduced based on these genetic studies. 
Experiments with the disrupted strains PKS-A, Dis-1 and 
Dis-2, and the deletion mutant Dis-3, demonstrate that 
addition of the NAC thioester of hexanoate can substitute 
for the synthetic functions of FAS-1 and FAS-2, but at 
significantly reduced efficiency. This observation and the 
results of three control experiments suggest the need for 
physical association of the PKS and at least one of the FAS 
proteins to initiate norsolorinic acid synthesis. Such a 
proposed PKS-FAS complex has not been demonstrated 
previously for multidomain type I PKS and FAS enzymes, 
although for the bacterial type II particulate FAS and PKS 
enzymes it is possible that FAS catalytic elements may be 
shared in both fatty acid and polyketide synthesis [30,31]. 
Results and discussion 
The experimental approach used here was based on a series 
of earlier incorporation experiments. Suspended cells of a 
mutant strain of Aspergdhs parasiticus (ATCC 24551) 
blocked in the ability to produce aflatoxin B, (compound 5) 
accumulated the intermediate averufin (compound 4), 
which contains the C, side chain present in norsolorinic 
acid (compound 3). Under a defined set of conditions 
[l-13C]hexanoic acid was observed to give an intact 
incorporation of 3-4 %  at C-l’ in 4, over a background of 
-0.5 %  at alternating sites derived from the C-l of acetate 
[Zl-231. The latter pattern of incorporation was expected to 
occur because of B-oxidation of [l-13C]hexanoic acid to 
[1-13C]acetate and its incorporation throughout the 
molecule [Zl-231. Under identical conditions the NAC 
thioester of hexanoate gave an unprecedented 22 %  
specific incorporation, again superimposed on an acetate- 
derived background of -0.5 %  per site. In contrast, 
[l-r3C]butyrate gave only randomization of label whether 
administered as the free acid or NAC thioester [Zl]. 
The A. parasiticus mutants Dis-1, Dis-2 and Dis-3 were 
generated by mutagenesis of a norsolorinic acid accumu- 
lating mutant and were incapable of producing norsolo- 
rinic acid or any other later intermediate in aflatoxin 
biosynthesis [28]. As Dis-1 and Dis-2 were generated by 
insertional mutagenesis atfas-1, the gene encoding one of 
the FAS enzymes necessary for aflatoxin biosyntheis, the 
PKS should be unaffected; it was thus expected that in 
these mutants hexanoic acid, and particularly hexanoyl- 
NAC, could substitute for the defective FAS apparatus 
and restore norsolorinic acid production. To determine the 
extent of conversion of the putative C, starter units, the 
substrates were directly supplied to liquid cultures of the 
respective mutants. Dis-1, Dis-2 and Dis-3 were initially 
fermented on Adye and Mateles medium [25] for 48 h. 
After 48 h of growth, the mycelia were vacuum filtered 
and transferred (10 g 125 ml-l) into replacement medium 
[25], at which time the precursors were also added. The 
cell suspensions were allowed to grow an additional 48 h, 
after which the products of fermentation were isolated by 
extraction, analyzed by thin-layer chromatography (TLC) 
and quantified by high pressure liquid chromatography 
(HPLC) analysis. 
The method used in these experiments was comparable to 
that used for earlier whole-cell incorporations with the 
averufin-accumulating mutant [Zl], and we were therefore 
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surprised to find that hexanoic acid failed to support 
norsolorinic acid production in any of the three FAS-1 
mutants (Table 1). In contrast, hexanoylNAC, the more 
effective C, precursor in the previous experiments, afforded 
a 0.4 % and 2 % conversion to norsolorinic acid in Dis-1 and 
Dis-2, respectively, and a trace of aflatoxin B, synthesis in 
both. Unlike these insertionally inactivated mutants, Dis-3 
arises from an apparent double crossover event, and contains 
a large deletion within fas-1 that extends beyondpks-A (see 
below). It failed to support detectable synthesis of any 
anthraquinone. As a control, averufin (compound 4), an 
intermediate occuring later in the pathway after the 
requirement for any of the modified gene products, was 
efficiently converted to aflatoxin by all three of these 
mutants (Table 1). In sum, these results show that, although 
the transformation of C, units was unexpectedly poor in the 
two insertionally inactivated mutants, the later enzymes of 
the biosynthetic pathway were fully functional. 
P-oxidation is expected to cause competing degradation of 
the administered C, units. To control for this effect, 
incubations with suspended Dis-2 cells were repeated in 
the presence of two degradation inhibitors, 4-pentynoic 
acid (compound 6) and 3-(tetradecylthio)propionic acid 
(compound 7) [32] (Fig. 3). These inhibitors had no effect 
on the transformation of hexanoic acid and only 
compound 7 gave minor improvement in the conversion 
of hexanoylNAC to norsolorinic acid (compound 4) (Table 
2). The low efficiency of hexanoylNAC conversion to 
norsolorinic acid in these strains is thus unlikely to be 
caused by enhanced p oxidation. 
The parent strain of Dis-1, Dis-2 and Dis-3 is a UV- 
generated mutant of wild-type A. parasiticas SU-1 selected 
Table 1 
Use of hexanoic acid/NAG by FAS mutant strains. 
Strain Substratea Norsolorinic Aflatoxin B, 
acid (% converted) 
(% converted)b 
Dis-1 Control (no substrate) - 
Dis-1 Hexanoic acid - - 
Dis-1 HexanoylNAC 0.4 % 0.3 % 
Dis-1 Averufin - 33 o/o 
Dis-2 Control (no substrate) - 
Dis-2 Hexanoic acid - - 
Dis-2 HexanoylNAC 2 o/o 0.4% 
Dis-2 Averufin - 45 % 
Dis-3 Control (no substrate) - 
Dis-3 Hexanoic acid - - 
Dis-3 HexanoylNAC - 
Dis-3 Averufin - 59 o/o 
aHexanoic acid/NAG (15 mg) or averufin (10 mg) was dissolved in 
1.5 ml of dimethylformamide (DMF). 
bDashes indicate <0.05 O/o conversion for norsolorinic acid and 
<O.Ol O/o conversion for aflatoxin B,. 
Figure 3 
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for its ability to accumulate norsolorinic acid (NOR-l, 
ATCC 24690) [33]. To ensure that: the low conversions of 
hexanoylNAC by Dis-1 and Dis-2 were not the result of 
an inherent limitation of NOR-l, hexanoic acid and its 
NAC thioester were administered to this strain. To 
distinguish between the endogenous production of 
norsolorinic acid and that derived from the externally 
supplied C, units, the C, units were administered in 13C 
form to suspended NOR-l cells, exactly as had been done 
for Dis-1 and Dis-2. The total amount of norsolorinic acid 
produced in each experiment was accurately assessed by 
quantitative HPLC analysis, and the amount resulting 
from incorporation of the C, precursor was judged by the 
proportion of the product bearing 13C label. Addition 
of [l-13C]hexanoic acid gave a specific incorporation of 
2 %; when the corresponding NAC thioester was added, 
16 % incorporation was observed. The percent conver- 
sions into norsolorinic acid, calculated as the ratio of the 
[13C]norsolorinic acid produced to the labeled C, unit 
administered, were 3 % and 39 % for hexanoic acid and its 
corresponding NAC thioester, respectively. As these data 
were obtained by the same method as that used in Tables 
1 and 2, they can be directly compared. The conversion is 
considerably more efficient in the parent NOR-l strain, in 
complete accord with earlier experiments [al]. 
These incorporations and calculated conversions are 
entirely consistent with the earlier reported experiments 
with the averufin-accumulating mutant [Zl], and indicate 
no impairment of either the FASs or the PKS in NOR-l. 
The poor conversions of hexanoylNAC into norsolorinic 
acid in Dis-1 and Dis-2 must have some other explan- 
ation. The results with P-oxidation inhibitors exclude 
competing degradation. Mapping experiments show that 
the promoter region between t-he divergently transcribed 
fus-l and &s-Z genes is unaffected by the insertional 
inactivation event, and Southern blots demonstrate 
unequivocally that only fax-2 is disrupted, so it is unlikely 
that lowered expression of FASZ protein could explain the 
low efficiencies of hexanoylNAC transformation. Having 
discounted all of these possible explanations, we suggest 
that hexanoylNAC cannot effectively ‘load’ onto the PKS 
by itself, as would be anticipated based on extensive 
experimentation with NAC thioesters in other polyketide 
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Table 2 
Effect of P-oxidation inhibitors on FAS mutant strain Dis-2. 
Substratea 
Control 
(no substrate) 
p-oxidation Norsolorinic acid Aflatoxin B, 
inhibitorb (o/o converted)c (% converted)c 
None - - 
HexanoylNAC None 5 %  0.3 %  
HexanoylNAC 4-Pentynoic acid 5 o/o 0.2 o/, 
HexanoylNAC 3-(Tetradecylthio)- 8 o/o 0.3 o/o 
propanoic acid 
al 5 mg of hexanoic acid/NAG was dissolved in 1.5 ml of DMF. 
b50 kmol of 4-pentynoic acid or 3-(tetradecylthio)propanoic acid was 
solubilized in DMF with the appropriate substrate. 
CDashes indicate <0.05 O/o conversion for norsolorinic acid and 
<O.Ol O/o conversion for aflatoxin B,. 
biosynthetic systems. Physical association of FAS-1, PKS 
and perhaps also FAS-2 is proposed to be necessary for 
efficient synthesis of norsorlorinic acid (compound 3) (Fig 
4). Disruption of j&s-l gives rise to the synthesis of a 
protein defective in its ability to correctly assemble and 
contribute to the efficient transfer of the hexanoyl unit to 
the PKS to begin aflatoxin biosynthesis. Of possible 
importance in this connection, it is recalled that, while 
other highly similar fungal PKSs have been observed to 
have two ACP domains,pkA contains only one [27]. 
The sensitivity of the HPLC assay is sufficient that 
-0.05 %  conversion to norsolorinic acid could be 
detected. Although we failed to observe hexanoic acid 
use in Dis-1 and Dis-2 under any conditions, it remains 
possible that it occured at efficiencies that were too low 
to be observed. Alternatively, the reaction may have been 
complicated by hindered association of the activated C, 
units (presumably as hexanoylCoA) with the putative 
PKS-FAS complex. That hexanoic acid is incorporated 
into norsolorinic acid (compound 3) in NOR-l with about 
the same efficiency as its NAC thioester is in Dis-1 and 
Dis-‘2 suggests that incorporation does occur in Dis-1 and 
Figure 4 
Model for the organization of FAS-1, FAS-2 
and PKS-A proteins and the genes that 
encode them. Divergent promoters drive the 
transcription of the fas-7 and fas-2 genes, 
whereas the pks-A gene is located further 
away. It is postulated that the proteins that 
are produced associate to initiate aflatoxin 
biosynthesis. 
Dis-2, but at undectable levels. As would be expected, 
controls using PKS-A, the comparably disrupted PKS 
mutant [34], failed to convert either hexanoic acid or 
hexanoylNAC to an anthraquinone. 
Significance 
Type I polyketide synthases are high molecular weight 
proteins containing multiple domains, each capable of 
catalyzing one of a sequence of individual reactions in 
the biosynthesis of a given natural product. In contrast, 
type II polyketide synthases, typically found in bacteria, 
form multienzyme complexes in which each component 
enzyme catalyzes a reaction that is used reiteratively. 
The biosynthesis of the potent environmental carci- 
nogen aflatoxin B, shows an interesting combination of 
these characteristics. It requires a simple type I PKS 
that is apparently capable of only non-reductively 
homologating a C, primer by reaction with seven 
malonates to give the anthrone 2. This C, primer is 
synthesized by a pair of independently transcribed type I 
FASs. Two mutants, Dis-1 and Dis-2, generated by 
insertional inactivation of one of the FAS genes, fas-1, 
are incapable of producing norsolorinic acid 
(compound 3) or aflatoxin (compound 5). However,  in 
the presence of hexanoylNAC, a viable surrogate of 
hexanoylCoA - the presumed product of the 
specialized FASs - production of compounds 3 and 5 
was restored, but at a much reduced efficiency 
compared to that seen in the parent strain NOR-l.  
On  the basis of control experiments, it is proposed that 
FAS-1 (and possibly also FAS-2) is required to mediate 
transfer of the synthetic C, primer to the PKS (perhaps 
by direct transfer without the need for conversion to the 
CoA ester) to initiate aflatoxin biosynthesis. Although 
the nature of the proposed channeling is not clear, the 
reason for the poor efficiencies of anthraquinone 
synthesis in Dis-1 and Dis-2 mutants may be explained 
by the production of a modified FAS-1. This would fail 
to complex with PKS or form suboptimal complexes 
with the PKS, perhaps by faulty geometry, reducing the 
l.l PKS-A/FAS-1 & -2 association ? 
468 Chemistry & Biology 1996, Vol3 No 6 
effectiveness of primer binding and transfer. Yeast FAS 
is known to form an a+& structure. Neither the quater- 
nary state of the related Aspergillus FASs nor the relative 
stoichiometry of the postulated PKWFAS-l/FAS-2 
complex involved in aflatoxin biosynthesis are known. 
By contrast the modular type I PKSs found often 
in Streptomyces more closely resemble animal FASs 
and, like these multienzymes, appear to function as 
homodimers [351. 
Materials and methods 
Hexanoic acid and N-acetylcysteamine were purchased from Aldrich 
(Milwaukee, WI). Labeled [l -13C]hexanoic acid was obtained from 
lsotec (99 % 13C; Miamisburg, OH). The P-oxidation inhibitor 
4-pentynoic acid was purchased from Aldrich and 3-(tetradecyl- 
thio)propanoic acid was a generous gift of Professor J.C. Vederas 
(University of Alberta). ‘H-NMR and 13C-NMR spectra were recorded 
on a Varian UnityPlus 400 spectrometer. Chemical shifts for ‘H- and 
13C-NMR spectra are reported in ppm referenced to d,-chloroform 
(7.26 ppm) and d,-dimethylsulfoxide (39.7 ppm), respectively. 
Synthesis of substrates 
The synthesis of hexanoylNAC was carried out as described elsewhere 
[21]; reported melting point (mp) 44-46 “C [211, found mp 43-45 “C. 
‘H NMR (400 MHz, CDCI,) 6: 6.0-5.9 (m, 1 H, NH), 3.43 (d x t, 
J= 6.3, 5.9 Hz, 2H, -CH,NH-), 3.02 (t, J = 6.6 Hz, 2H, -CH,S-), 
2.57 (t, J= 7.5 Hz, 2H, -CH,CO-), 1.97 (s, 3H, CH,CO-), 1.71-1.63 
(t, J= 7.4 Hz, 2H, -CH,CO-), 1.33-1.28 (m, 6H, -CH,CH,CH,-), 
0.90 (J = 6.3 Hz, 3H, -CH,). 
replacement medium. Typically substrates, hexanoic acid/NAG thio- 
ester (15 mg) or averufin (10 mg) together with 50 pmol of the desired 
p oxidation inhibitor, when appropriate, were dissolved in 1.5 ml of 
dimethylformamide and added to the mycelial suspensions, which were 
grown for an additional 48 h. The cells were harvested by vacuum 
filtration, flash frozen in liquid nitrogen and the metabolites extracted by 
steeping the cells in acetone for 1 h at 50 “C. The acetone extract was 
concentrated under vacuum and lyophilized. The biosynthesized 
products obtained from a single 125-ml culture were typically 
solubilized in 5 ml of methanol. Metabolite production was measured 
qualitatively by TLC (under long-wave UV). Norsolorinic acid 
(R,= 0.93) and versicolorin A (R,= 0.30) were detected using a 
ternary mixture of 8:1.8:0.2 of hexaneiethyl acetate:acetic acid while 
0-methylsterigmatocystin (R,= 0.68) and aflatoxin 6, (R,= 0.56) were 
separated with a 6:3:1 mixture of chloroform:ethyl acetate:formic acid. 
Analytical methods 
Southern and northern blots were performed using standard procedures 
1361. Quantitative determination of metabolite production was achieved 
by HPLC analysis. A reverse-phase Phenomenex C-18 column 
(250 x 4.60 mm; Torrance, CA) was used in conjunction with a Varian 
5020 liquid chromatograph equipped with a 50-~1 injection loop and an 
Applied Biosystems diode array UV detector (Model 1000s; Ramsey, 
NJ). Norsolorinic acid (tr = 14.6 min) production was measured using an 
isocratic gradient (20% of 0.1 % trifluoroacetic acid in 
water:acetonitrile) while amounts of versicolorin A (f = 41.3 min), 
0-methylsterigmatocystin (tr = 29.6 min) and aflatoxin 6, (tr = 16.36 
min) were determined with a gradient (70 % to 40 O/o in 55 min, 0.1 O/o 
trifluoroacetic acid in water:acetonitrile). Typically, metabolites generated 
from a 125.ml culture were solubilized in 5 ml of methanol, filtered 
(Alltech #2167 nylon 0.45 pm; Deerfield, IL) and 50 )LI of this solution 
was analyzed by HPLC. Integrated peak areas were averaged based 
upon three injections and these data are entered in Tables 1 and 2. 
Organisms 
The Aspergillus parasiticus norsolorinic acid accumulating mutant 
(NOR-l, ATCC 24690) was purchased from the American Type 
Culture Collection (ATCC; Rockville, MD). The A. parasiticus disruption 
mutant strains PKS-A, Dis-1 and Dis-2 and the deletion mutant Dis-3 
were a gift of Professor J.E. Linz and co-workers [281. 
Media 
The basal medium [25] used to initially culture the A. parasiticus strains 
contained per liter: sucrose, 50 g; potassium phosphate monobasic, 10 
g; 
ammonium sulfate, 3 g; magnesium sulfate (anhydrous), 1 g; and 
trace metals [25], 2 ml. The replacement medium of Adye and Mateles 
was modified to contain per liter: glucose, 1.62 g; potassium phosphate 
monobasic, 5 g; potassium chloride, 0.5 g, magnesium sulfate (an- 
hydrous), 0.25 g; and trace metals, 2 ml. All media were autoclaved 
(140 “C, 20 psi) for 20 min and cooled to room temperature prior to use. 
Incorporation of [l -13Cl-labeled substrates into norsolorinic acid 
The [l -i3CI-labeled fatty acid/NAG substrates were supplied to the A. 
parasiticus norsolorinic acid accumulating mutant strain NOR-l, the 
metabolites extracted following the procedure described above, and 
the total concentration estimated by UV spectroscopy. Following 
lyophilization, norsolorinic acid was most easily purified by direct 
redrystallization from acetone. In each case, apbr&imately 4 mg of 
purified material was obtained from four 125-ml cultures. 
‘H NMR (400 MHz, CDCI,) 6: 7.12 (s, 1 H, H-4), 7.05 (d, j= 2.4 Hz, 1 H, 
H-5), 6.53 (d, J= 2.4 Hz, 1 H, H-7), 2.73 (t, J= 7.2 Hz, 2H, H-l 2), 1.59 
(m, 2H, H-13), 1.25 (m, 4H, H-14/H-15), 0.81 (t, J=6.8 Hz, 3H, H-16). 
13C NMR (100 MHz, d, dimethylsulfoxide) 6: 202.7 (C-l’), 188.3, 
181.0, 165.1, 164.1, 162.2, 160.8, 134.8, 134.6, 121.4, 119.2 (?), 
108.8, 108.4, 108.1, 43.6, 30.7, 22.6, 21.9, 13.9, C-2 not detected. 
Culture techniques 
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